Media News

Creating the Leaders of Tomorrow: The Valuable 500 Reach Milestone for ‘Generation Valuable’ on International Day for Persons with Disabilities

Powered by Verizon, the Valuable 500 has enlisted 75 Generation Valuable Mentees and Mentors Launching in January 2023, the Generation Valuable participants will gain access to world-class creative leadership courses and collaborative opportunities with the other multinational corporations taking part in the initial cohort. The programme modules include Creative Leadership, Leadership Identity, Strategic Thinking, Business for Good/ESG, and...

BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine

VANCOUVER, BC, Dec. 1, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce the successful sterile and bacteria-free test-run production of BVX-0918, the Company's bi-haptenized autologous ovarian cancer vaccine.  The complete manufacturing of BVX-0918 from a cancer patient's ovarian tumor now validates...

Commercial Dishwashers Destroy Protective Layer in Gut

Residue from rinse agents is left behind on dishes after they are cleaned in professional-grade dishwashers. This damages the natural protective layer in the gut and can contribute to the onset of chronic diseases, as demonstrated by researchers working with organoids at the Swiss Institute of Allergy and Asthma Research, an associated UZH institute. ZURICH, Dec. 1, 2022 /PRNewswire/...

Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826’s Treatment of Female Androgenetic Alopecia in China Was Met

SUZHOU, China, Dec. 1, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("KintorPharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced results of phase II clinical trial of pyrilutamide (KX-826), a potential first-in-class topical drug developed by the company, in China for the treatment of adult female androgeneticalopecia (AGA). In the study, KX-826 has demonstrated...

MGI Cements Its Presence and Contribution in Singapore’s Genomics Landscape at ESMO Asia Congress 2022

SINGAPORE, Dec. 1, 2022 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, will join global and Asian cancer professionals at the ESMO Asia Congress 2022 taking place 2-4 December in Singapore. In addition, MGI will introduce a free trial campaign on its latest sequencer DNBSEQ-G99* for early...

111, Inc. Announces Third Quarter 2022 Unaudited Financial Results

SHANGHAI, Dec. 1, 2022 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Key Results Net revenues were RMB3.35 billion (US$470.8 million), representing an...

Encore Medical Education announces publication of the Official Best of SABCS® News Highlights summarizing key trial results from the 2022 SABCS®

Best of SABCS® News Highlights coverage will provide daily expert video summaries along with original presentation slides of the most significant breast cancer trials for oncologists worldwide. SAN ANTONIO, Dec. 1, 2022 /PRNewswire/ -- Encore Medical Education, a US-based medical education company will launch the 2022 edition of the Best of SABCS®...

SK Biopharmaceuticals Names Donghoon Lee, Head of Bio Investment Center of SK Inc., as New CEO

Mr. Lee brings expertise in global new biz development to further strengthen SK Biopharmaceuticals as SK Group's key bio business PANGYO, South Korea, Nov. 30, 2022 /PRNewswire/ -- SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that it has named Mr. Donghoon Lee, Executive Vice President and Head of Bio Investment Center...

New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio

Return to the index page SQL ERROR Can't connect to MySQL server on '192.168.120.250' (111) An sql error occurred while fetching this page. Please contact an administrator if this problem persists. Powered by PRN Asia 2011 PRN Asia

Dr Ivan Puah Shares 5 Beauty & Body Sculpting Trends In The Cosmetic & Aesthetic Industry For 2023

SINGAPORE, Dec. 1, 2022 /PRNewswire/ -- As we look forward to the new year, Dr Ivan Puah, Medical Director at Amaris B. Clinic, who has more than 15 years of medical aesthetics and surgical body contouring experience, shares five beauty and body sculpting trends expected to take centre stage in 2023. Dr Ivan Puah, Medical Director at...